Abstract:Hematoxylin and eosin (H&E) stained histologic sections contain invaluable information that remains largely untapped because of its complexity. To this end, AI applications employing deep learning (DL) can facilitate the translation of image data to enable human interpretation and yield novel oncological insights that would have otherwise remained imperceptible. DL-based methodologies are multimodal, capable of integrating imaging with clinicogenomic data to furnish a more holistic perspective and affording more accurate predictions in oncology. Here, we developed an unsupervised DL workflow to analyze 1,799 H&E images of lung cancer (NSCLC n = 951; SCLC n = 50; others n = 798) incorporating comprehensive patient-level clinical data (electronic health records [ConcertAI]) integrated with genomics (WES and RNA-seq [Caris Labs]). There are three steps in our approach: (1) image preprocessing and filtering, yielding > 30 million image patches; (2) utilizing pretrained SimCLR models from 57 public oncology histopathology datasets with ResNet-18 as a backbone structure to extract 512-dimensional-feature vectors for each patch; (3) using three unsupervised clustering methods (kmeans, DBSCAN, Leiden clustering) to cluster patches and selected Leiden clustering. We identified 635 primary imaging clusters using an elbow method and generated an image feature matrix by calculating correlations between each patch and cluster centroids; these were aggregated and mapped back to source slides. In this proof-of-concept, distinct image feature patterns characterized SCLC and NSCLC samples. For SCLC, one of the salient features was the presence of hemorrhage, which may be associated with higher rates of fine-needle aspiration biopsy procedure for SCLC compared with NSCLC which was confirmed in the EHR data (p = 0.032). Derived morphological clusters were correlated with tumor-immune genomic features (Tumor Mutational Burden [TMB], Immunologic Constant of Rejection [ICR], and Miracle scores1) serving as predictors of response to immune-checkpoint inhibitor therapy. By applying linear models, we detected 11, 96 and 249 significantly associated imaging clusters, respectively, highly enriched with immune cells e.g., plasma cells, macrophages, lymphocytes, and supporting an infiltrated and inflamed tumor-immune microenvironment. In summary, a multimodal, unsupervised deep learning workflow combining H&E imaging with clinicogenomic data was developed to identify histologic feature clusters associated with well-established tumor-immune genomic signatures of NSCLC immune infiltration and molecular phenotypes. These studies demonstrate enormous potential to yield histopathological and translational insights in NSCLC and SCLC that can empower clinicians to make better therapeutic response predictions. Citation Format: Si Wu, Yujie Zhao, Hugo Luo, Kevin Kolahi, Thanh Bui, Xu Shi, Aditee Shrotre, Alexander Liede, Xi Zhao, Josue Samayoa, Weilong Zhao. Integrating real-world histopathological and clinicogenomic data from 1799 lung cancer patients by applying unsupervised deep learning [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2310.

Linking cellular activation to cytoskeletal reorganization: Wiskott–Aldrich syndrome as a model

Deep learning in cancer pathology: a new generation of clinical biomarkers

Machine learning enabled prediction of digital biomarkers from whole slide histopathology images

Regression-based Deep-Learning predicts molecular biomarkers from pathology slides

Deep learning-based survival prediction for multiple cancer types using histopathology images

Rate and yield of OH-induced strand break formation of polynucleotides and DNA.

Deep Learning-Based Prediction of Molecular Tumor Biomarkers from H&E: A Practical Review

Biological insights and novel biomarker discovery through deep learning approaches in breast cancer histopathology

A digital pathology AI model to predict immune-oncology biomarker status and pembrolizumab response in a real-world cohort of patients with colorectal and breast cancer.

Determining breast cancer biomarker status and associated morphological features using deep learning

Abstract 2313: Multi-modal deep learning to predict cancer outcomes by integrating radiology and pathology images

Biologic and Prognostic Feature Scores from Whole-Slide Histology Images Using Deep Learning

Deep learning in cancer genomics and histopathology

Artificial Intelligence Predicts Multiclass Molecular Signatures and Subtypes Directly from Breast Cancer Histology

Fully transformer-based biomarker prediction from colorectal cancer histology: a large-scale multicentric study

Abstract 2310: Integrating real-world histopathological and clinicogenomic data from 1799 lung cancer patients by applying unsupervised deep learning

Deep Learning-based Prediction of Breast Cancer Tumor and Immune Phenotypes from Histopathology

Deep learning supported discovery of biomarkers for clinical prognosis of liver cancer

Abstract 6191: Simultaneous prediction of tumor microenvironment biomarkers from pathology slides using multi-task deep regression

A Deep Learning Approach for the Identification of the Molecular Subtypes of Pancreatic Ductal Adenocarcinoma Based on Whole-Slide Pathology Images

Joint multi-task learning improves weakly-supervised biomarker prediction in computational pathology